Abstract
It has been shown that signalings from c-kit and gpl30, the signal-transducing receptor component of the IL6 receptor, act synergistic for the ex-vivo expansion of multipotential hematopoietic progenitors. A similar synergistic effect has been demonstrated for signalings from c-kit, c-mpl, and flt3. While c-kit is activated by stem cell factor (SCF), gpl30 can be activated by the complex of soluble IL-6 receptor (sIL-6R) and interleukin-6 (IL-6). Recently, a bioactive designer cytokine, H-IL-6, a fusion protein consisting of SIL-6R and IL-6 linked by a flexible peptide chain has been shown to expand human hematopoietic colony-forming cells. We tested the activity of H-IL-6 alone and in combination with TPO, SCF, and the flt3 ligand (FL) on mobilized purified human primitive CD34++/CD90+ progenitor cells in a 7 day serum-free liquid culture system. Apart from a moderate expansion of CD34+ cells (2.5-fold to 3.5-fold) the most striking effects of H-IL-6 were observed in megakaryopoiesis. In contrast to TPO, H-IL-6 alone was not sufficient for survival or proliferation of CD34++/CD90+ progenitor cells. Yet the combination of H-IL-6 and TPO expanded CD41+ cells to the same extent as did the combination of TPO + SCF (20-fold). A maximum yield of megakaryocyte progenitors (more than 50-fold) was obtained with the combination of H-IL-6, TPO, and SCF.
Keywords
- Stem Cell Factor
- Fit3 Ligand
- Cytokine Combination
- Human Hematopoietic Progenitor Cell
- Megakaryocyte Progenitor
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sui XW, Kohichiro T, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nakahata T: gpl30 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. PNAS 92: 2859, 1995.
Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM: Effects of Recombinant Human Thrombopoietin Alone and in Combination with Erythropoietin and Early-Acting Cytokines on Human Mobilized Purified CD34+ Progenitor Cells Cultured in Serum-Depleted Medium. Stem Cells 15: 18, 1997.
Borge OJ, Ramsfjell V, Veiby OP, Murphy MJ, Lok S, Jacobsen SEW: Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 88: 2859, 1996.
Ebihara Y, Tsuji K, Lyman SD, Sui XW, Yoshida M, Muraoka K, Yamada K, Tanaka R, Nakahata T: Synergistic action of Flt3 and gpl30 signalings in human hematopoiesis. Blood 90(11): 4363, 1997.
Kaushansky K, Broudy VC, Grossmann A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH: Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96: 1683, 1995.
Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88: 429, 1996.
Rasko JEJ, OFlaherty E, Begley CG: Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid, and granulocy-te/macrophage progenitors. Stem Cells 15: 33, 1997.
Young JC, Bruno E, Luens KM, Wu S, Backer M, Murray LJ: Thrombopoietin stimulates megakary-ocytopoiesis, myelopoiesis, and expansion of CD34(+) progenitor cells from single CD34(+)Thy-1(+)Lin(-) primitive progenitor cells. Blood 88: 1619, 1996.
Ramsfjell V, Borge OJ, Cui L, Jacobsen SEW: Thrombopoietin directly and potently stimulates mul-tilineage growth and progenitor cell expansion from primitive (CD34(+)CD38(-) ) human bone marrow progenitor cells—Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory Ef-Fects of TGF-beta and TNF-alpha. J Immunol 158(11): 5169, 1997.
Fischer M, Goldschmitt J, Peschel C, Brakenhoff JPG, Kallen KJ, Wollmer A, Grotzinger J, Rose-John, S: A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15(2): 142, 1997.
Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL: Role of c-mpl in Early Hematopoiesis. Blood 92: 4, 1998.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Birkmann, J., Rose-John, S., Smetak, M., Sievert, T., Gallmeier, W.M. (1999). Hyper-IL-6 (H-IL-6), a Fusion Protein of Soluble IL-6 Receptor (Sil-6R), and Interleukin-6 (IL-6), Acts Synergistic with Thrombopoietin (TPO) and Stem Cell Factor (SCF) in Expanding Megakaryocyte Progenitors from Human Cd34++/Cd90+ Cell. In: Abraham, N.G., Tabilio, A., Martelli, M., Asano, S., Donfrancesco, A. (eds) Molecular Biology of Hematopoiesis 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4797-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4797-6_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7173-1
Online ISBN: 978-1-4615-4797-6
eBook Packages: Springer Book Archive